Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: GMP audits and inspections

The Role of GMP in Ensuring Drug Safety in Asia: PMDA, NMPA, and KFDA Perspectives

Posted on January 24, 2025 By digi

The Role of GMP in Ensuring Drug Safety in Asia: PMDA, NMPA, and KFDA Perspectives How GMP Ensures Drug Safety in Asia: Insights from PMDA, NMPA, and KFDA Introduction to GMP and Drug Safety Drug safety is a top priority in the pharmaceutical industry, especially in regions with rapidly growing markets like Asia. Good Manufacturing…

Read More “The Role of GMP in Ensuring Drug Safety in Asia: PMDA, NMPA, and KFDA Perspectives” »

GMP in Asia (PMDA, NMPA, KFDA)

How to Achieve GMP Compliance for Drug Manufacturing in Latin America

Posted on January 24, 2025 By digi

How to Achieve GMP Compliance for Drug Manufacturing in Latin America A Step-by-Step Guide to GMP Compliance for Pharmaceutical Manufacturers in Latin America Introduction to GMP Compliance in Latin America Good Manufacturing Practices (GMP) are vital for ensuring the safety, efficacy, and quality of pharmaceutical products. In Latin America, regulatory bodies such as Brazil’s Agência…

Read More “How to Achieve GMP Compliance for Drug Manufacturing in Latin America” »

GMP in Emerging Markets (GCC, Latin America, Africa)

Schedule M Revised and Its Impact on the Manufacturing of Biopharmaceuticals in India

Posted on January 23, 2025 By digi

Schedule M Revised and Its Impact on the Manufacturing of Biopharmaceuticals in India How Schedule M Revised Shapes Biopharmaceutical Manufacturing in India Introduction to Biopharmaceuticals and Schedule M Revised Biopharmaceuticals represent a cutting-edge segment of the pharmaceutical industry, encompassing products such as monoclonal antibodies, vaccines, and gene therapies. These complex and highly sensitive products demand…

Read More “Schedule M Revised and Its Impact on the Manufacturing of Biopharmaceuticals in India” »

GMP in India

Health Canada’s GMP Requirements for Biopharmaceuticals

Posted on January 23, 2025 By digi

Health Canada’s GMP Requirements for Biopharmaceuticals An In-Depth Exploration of Health Canada’s GMP Requirements for Biopharmaceuticals Introduction to Health Canada GMP for Biopharmaceuticals Biopharmaceuticals represent a rapidly growing segment of the pharmaceutical industry, offering innovative treatments for complex diseases. However, the manufacturing of these products involves unique challenges, requiring stringent adherence to Good Manufacturing Practices…

Read More “Health Canada’s GMP Requirements for Biopharmaceuticals” »

GMP in North America (FDA, Health Canada)

How to Align GMP Practices with EMA’s Regulatory Standards

Posted on January 23, 2025 By digi

How to Align GMP Practices with EMA’s Regulatory Standards A Step-by-Step Guide to Aligning GMP Practices with EMA Regulatory Standards Introduction to EMA GMP Standards The European Medicines Agency (EMA) sets stringent Good Manufacturing Practices (GMP) standards to ensure the quality, safety, and efficacy of pharmaceutical products within the European Union (EU). Compliance with EMA…

Read More “How to Align GMP Practices with EMA’s Regulatory Standards” »

GMP in Europe (EMA, MHRA)

How to Prepare for PMDA GMP Inspections in Japan

Posted on January 23, 2025 By digi

How to Prepare for PMDA GMP Inspections in Japan A Step-by-Step Guide to Preparing for PMDA GMP Inspections in Japan Introduction to PMDA GMP Inspections The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s regulatory authority for ensuring the safety, efficacy, and quality of pharmaceutical products. PMDA conducts Good Manufacturing Practices (GMP) inspections to evaluate…

Read More “How to Prepare for PMDA GMP Inspections in Japan” »

GMP in Asia (PMDA, NMPA, KFDA)

The Role of GMP in Pharmaceutical Manufacturing in the GCC Countries

Posted on January 23, 2025 By digi

The Role of GMP in Pharmaceutical Manufacturing in the GCC Countries How GMP Shapes Pharmaceutical Manufacturing in GCC Countries Introduction to GMP in the GCC The pharmaceutical industry in the Gulf Cooperation Council (GCC) countries, including Saudi Arabia, UAE, Qatar, Oman, Kuwait, and Bahrain, is undergoing significant growth. At the core of this growth is…

Read More “The Role of GMP in Pharmaceutical Manufacturing in the GCC Countries” »

GMP in Emerging Markets (GCC, Latin America, Africa)

How to Align GMP Practices with FDA Regulations for Pharma Manufacturing

Posted on January 23, 2025 By digi

How to Align GMP Practices with FDA Regulations for Pharma Manufacturing Aligning GMP Practices with FDA Regulations: A Comprehensive Guide for Pharma Manufacturing Introduction to GMP and FDA Regulations In the pharmaceutical industry, aligning Good Manufacturing Practices (GMP) with FDA regulations is essential for ensuring product safety, efficacy, and quality. The FDA enforces current Good…

Read More “How to Align GMP Practices with FDA Regulations for Pharma Manufacturing” »

GMP in North America (FDA, Health Canada)

Best Practices for Meeting Schedule M Revised GMP Standards in Indian Pharmaceutical Facilities

Posted on January 23, 2025 By digi

Best Practices for Meeting Schedule M Revised GMP Standards in Indian Pharmaceutical Facilities A Step-by-Step Guide to Meeting Schedule M Revised GMP Standards in India Introduction to Schedule M Revised Schedule M Revised under the Drugs and Cosmetics Rules, 1945, is a pivotal update for Good Manufacturing Practices (GMP) in the Indian pharmaceutical industry. These…

Read More “Best Practices for Meeting Schedule M Revised GMP Standards in Indian Pharmaceutical Facilities” »

GMP in India

The Impact of NMPA GMP Guidelines on Chinese Pharmaceutical Manufacturing

Posted on January 23, 2025 By digi

The Impact of NMPA GMP Guidelines on Chinese Pharmaceutical Manufacturing Examining the Influence of NMPA GMP Guidelines on China’s Pharmaceutical Industry Introduction to NMPA and GMP in China The National Medical Products Administration (NMPA), formerly known as the China Food and Drug Administration (CFDA), plays a pivotal role in regulating the pharmaceutical industry in China….

Read More “The Impact of NMPA GMP Guidelines on Chinese Pharmaceutical Manufacturing” »

GMP in Asia (PMDA, NMPA, KFDA)

Posts pagination

Previous 1 … 21 22 23 … 26 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme